Home›Research›Compare›Klotho vs NAD+
Peptide ComparisonKlotho vs NAD+
Both are Longevity & Cellular peptides.
NAD+
NAD
Half-life: ~1–2 hours (IV); variable (oral)
451 providers listed
Klotho carries stronger published evidence (Meta-analysis, 8 key studies) than NAD+ (RCT, 4); both are research compounds.
Klotho
Half-life
—
NAD+
Half-life
~1–2 hours (IV); variable (oral)
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Klotho |
| Oral administration option | NAD+ |
| More provider options (0 vs 451) | NAD+ |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Klotho
NAD+
Klotho
Klotho protein and cognitive function: a systematic review and meta-analysis
Association between soluble Klotho levels and calcification propensity T50 in patients with hemodialysis: a c…
Klotho heterozygosity does not modify cognitive decline in APOE ε4 carriers: analysis of a large biobank coho…
VSIG4 Expression During Renal Aging Is Accelerated by Type 2 Diabetes in Mice.
+4 more
NAD+
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and…
Mitochondrial quality control in human ageing and longevity.
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
About Klotho
Acts as a co-receptor for FGF23, regulating phosphate and vitamin D metabolism. As a circulating hormone, inhibits insulin/IGF-1 signaling to extend lifespan, activates Nrf2 antioxidant pathways, and suppresses TGF-β fibrotic signaling.
About NAD+
NAD+ is a coenzyme central to cellular energy metabolism, serving as an electron carrier in glycolysis, the citric acid cycle, and oxidative phosphorylation. It is also a required substrate for sirtuins (SIRT1–7) and PARP enzymes, which regulate DNA repair, gene expression, and mitochondrial biogenesis. NAD+ levels decline measurably with age; IV or subcutaneous delivery aims to restore intracellular pools more directly than oral precursors such as NMN or NR.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Klotho
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
NAD+
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Klotho
Not enough vendor pricing yet.
NAD+
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Longevity & Cellular Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Klotho vs NAD+ — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/klotho/nad-plus